OrbusNeich Medical Group (HKG:6929) reported $41.9 million in attributable profit for 2025, up 5.5% from $39.7 million in 2024, according to a Hong Kong bourse filing Thursday.
Earnings per share was $0.0508, compared with $0.0481 in the prior year.
Revenue increased 10% year on year to $180.5 million, figures showed.
The company also declared a dividend of HK$0.12 per share, payable June 26 to shareholders of record on June 16.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.